PARAGARD T380A (intrauterine copper contraceptive), 1 unit per carton together with an insertion tube and solid white... — FDA record D-0643-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Feb 4, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
PARAGARD T380A (intrauterine copper contraceptive), 1 unit per carton together with an insertion tube and solid white rod in a Tyvek polyethylene pouch, Rx Only, Manufactured by Teva Women's Health Inc. a subsidiary of Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 51285-204-01
Reason
Non-sterility
Classification
Class I
Recalling firm
CooperSurgical, Inc
Quantity
48,645 cartons
Agency-reported status
Terminated
Source record identifier
D-0643-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityLot # 517001,Exp 1/2024

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Feb 23, 2022
Recall initiation date
Feb 4, 2022
Center classification date
Mar 1, 2022
Termination date
Feb 6, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records